Folate metabolic enzymes

Folate metabolic enzymes represent a complex network of proteins that regulate the intracellular folate pool and facilitate the transfer of one-carbon units required for essential biosynthetic processes. This pathway is central to the de novo synthesis of purines and thymidylate, which are indispensable for DNA replication, repair, and RNA synthesis (Source: NIH Office of Dietary Supplements). Key enzymes in this system, such as dihydrofolate reductase (DHFR) and thymidylate synthase (TYMS), serve as critical therapeutic targets for antifolate drugs like methotrexate and pemetrexed (Source: StatPearls). By inhibiting these enzymes, drugs deplete the supply of reduced folates, leading to the cessation of nucleotide production and subsequent cell death, a strategy widely used in treating various cancers and autoimmune conditions like rheumatoid arthritis (Source: PubMed). Additionally, the folate cycle plays a vital role in the methionine cycle, influencing cellular methylation and homocysteine regulation, which has implications for cardiovascular health and fetal development (Source: NCBI). Consequently, genetic variations or deficiencies in this pathway are linked to diseases ranging from megaloblastic anemia to neural tube defects.

Other names

Folate cycleOne-carbon metabolismFolate metabolic pathwayFolate-mediated one-carbon metabolism (FOCM)

Competitive inhibition of folate-dependent enzymes (e.g., dihydrofolate reductase, thymidylate synthase, and glycinamide ribonucleotide formyltransferase) leading to the depletion of intracellular reduced folate pools and subsequent inhibition of DNA and RNA synthesis (Source: StatPearls, PubMed).